Glucose (Fasting)

Blood

Comprehensive Metabolic Panel (CMP)

Fasting glucose is your blood sugar measured after at least eight hours without food, reflecting how well your body maintains stable energy in the resting state. A preventive practice treats it as a foundational metabolic marker, since glucose control sits upstream of many chronic diseases of aging.

What It Measures

Blood sugar level after 8+ hour fast; metabolic health foundation marker

Optimal vs. Lab Range

Longevity Optimal

72–86 mg/dL

Target range for optimal health and longevity based on research.

Standard Lab

70–100 mg/dL

Population-based reference range from standard labs.

Why It Matters

Fasting glucose is a window into metabolic health, and even modest elevations carry meaning for healthspan long before diabetes develops. Values in the prediabetic and diabetic ranges reflect growing insulin resistance and raise the risk of cardiovascular disease, kidney disease, and other complications, while transient elevations can also come from stress or certain hormonal conditions. A low value can signal hypoglycemia, insulin excess, adrenal insufficiency, or liver disease. Because metabolic dysfunction is a central driver of accelerated aging, keeping fasting glucose in an optimal range is a high-leverage goal, best understood alongside HbA1c and fasting insulin.

When Low

Hypoglycemia, insulin excess, adrenal insufficiency, liver disease

When High

Prediabetes (100–125), diabetes (>126), stress, Cushing, pancreatitis

How to Optimize

Fasting glucose responds strongly to lifestyle, so strategies like time-restricted eating, reducing refined carbohydrates, and regular zone 2 exercise are powerful first-line levers for improving insulin sensitivity. A continuous glucose monitor can reveal how specific foods and habits affect your levels, sharpening these adjustments. When lifestyle change is not enough, clinicians may add physician-directed options such as berberine or metformin as part of a broader plan. Fasting glucose is best interpreted with HbA1c, fasting insulin, and HOMA-IR. Targets and treatment are individualized with your physician; this content is educational and not a substitute for medical advice.

Key Interventions & Linked Compounds

Strong evidence

Key Interventions

Time-restricted eating

zone 2 exercise

berberine

metformin (clinical)

CGM

Linked Compounds & Supplements

Berberine

Chromium

Alpha-lipoic acid

Cinnamon

Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.

Ordering Notes

Specimen

Serum or plasma (venous draw)

Patient prep

No fasting required. Maintain usual diet and medications unless advised.

Recommended cadence

Quarterly

Reporting unit

Confirm with the performing lab — units vary by region.

Pre-analytic notes

Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.

Recommended Follow-Up Actions

1
Confirm the result is reliable
Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift Glucose (Fasting).
2
Compare against optimal, not just lab range
Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.
3
Pair with related markers
Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.
4
Discuss interventions with a clinician
Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.
5
Re-test on a defined cadence
If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.